| VYRALYM ALLOVIR INC.
2024940 28 Apr 2020 | on 19 Feb 2024 | Class 005 Class 005 Pharmaceutical Products Cell cultures for medical purposes and veterinary purposes, namely virus specific T cells; Virus specific T cells for medical and clinical use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of virus associated cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations and substances for the treatment of viral infections | | | VYRALYM-M ALLOVIR INC.
2024941 28 Apr 2020 | on 19 Feb 2024 | Class 005 Class 005 Pharmaceutical Products Cell cultures for medical purposes and veterinary purposes, namely virus specific T cells; Virus specific T cells for medical and clinical use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of virus associated cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations and substances for the treatment of viral infections | | 
